[Noninvasive quantitative evaluation of cardiac reverse--effects of dilazep (adenosine like agent)].
作者信息
Morishita T, Arai C, Abe N, Takeuchi K, Hasegawa M, Takayama Y, Emori I, Yoshinori K
出版信息
Kokyu To Junkan. 1988 Jun;36(6):675-9.
PMID:3217607
Abstract
摘要
相似文献
1
[Noninvasive quantitative evaluation of cardiac reverse--effects of dilazep (adenosine like agent)].[心脏反向作用的非侵入性定量评估——双嘧达莫（腺苷样药物）]
Kokyu To Junkan. 1988 Jun;36(6):675-9.
2
[Polygraphic and electrocardiographic study of a new coronary therapeutic agent: dilazep].一种新型冠状动脉治疗药物：双嘧达莫的多导睡眠图和心电图研究
Clin Ter. 1980 Jan 31;92(2):155-63.
3
[Polycentric and hemodynamic experimentation with a new coronary active drug: dilazep].[一种新型冠状动脉活性药物：双嘧达莫的多中心血流动力学实验]
Clin Ter. 1976 Aug 31;78(4):303-62.
4
[Results of the clinical testing of a new coronary drug, Cormelian].[一种新型冠状动脉药物科米利安的临床试验结果]
Fortschr Med. 1972 Apr 6;90(10):399-404.
5
6
[Value of dilazep in the treatment of coronary insufficiency. A randomized and double-blind study on subjects with stable, exertion angina].
Minerva Cardioangiol. 1980 Jul-Aug;28(7-8):489-94.
7
[Cardiodynamic changes induced with dilazep in chronic coronary insufficiency].
G Ital Cardiol. 1980;10(12):1675-8.
8
[Dilazep].[双嘧达莫]
G Ital Cardiol. 1980;10(10):1419-25.
9
Cardiovascular effects of a single high dose of dilazep by oral route.单次口服大剂量双嘧达莫的心血管效应。
Int J Cardiol. 1986 Jun;11(3):337-48. doi: 10.1016/0167-5273(86)90038-0.
Zotero 插件